SPOTLIGHT -
Novagali Pharma has announced positive results from its Phase II trial of the preservative-free cationic emulsion, Catioprost.
Global partnership targets ROP in premature infants
An AI-supported telemedicine effort from Siloam Vision and Orbis International
Exonate shares results from Phase Ib/IIa trial of EXN407 eye drops for DR and DME
In addition to the primary safety and tolerability endpoints, the study also saw signals of biological response from EXN407
Genetic editing untangles one strand of the AMD web
The opportunities and challenges presented by CRISPR manipulation
Outlook Therapeutics receives positive CHMP opinion for bevacizumab for wet age-related macular degeneration
The European Commission is expected to make a decision about the application before the end of June
An alternative approach to spectacle independence
Laser blended vision is a proven modality for presbyopia treatment, but its principles can be reproduced with EDOF IOLs
How amyloid-beta peptide and tau protein demonstrate degeneration
Proteins common to Alzheimer disease play a significant role in glaucoma